SEI Investments’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.47M Buy
159,937
+10,129
+7% +$157K ﹤0.01% 1567
2025
Q1
$2.23M Sell
149,808
-73,079
-33% -$1.09M ﹤0.01% 1596
2024
Q4
$2.95M Sell
222,887
-93,071
-29% -$1.23M ﹤0.01% 1520
2024
Q3
$4.49M Sell
315,958
-17,782
-5% -$253K 0.01% 1335
2024
Q2
$4.32M Sell
333,740
-39,235
-11% -$508K 0.01% 1292
2024
Q1
$5.18M Buy
372,975
+23,525
+7% +$327K 0.01% 1205
2023
Q4
$4.99M Sell
349,450
-12,030
-3% -$172K 0.01% 1191
2023
Q3
$5.59M Buy
361,480
+34,787
+11% +$538K 0.01% 1109
2023
Q2
$5.13M Buy
326,693
+14,069
+5% +$221K 0.01% 1181
2023
Q1
$5.15M Sell
312,624
-16,288
-5% -$268K 0.01% 1174
2022
Q4
$5.13M Buy
328,912
+14,872
+5% +$232K 0.01% 1037
2022
Q3
$4.07M Buy
314,040
+12,127
+4% +$157K 0.01% 1189
2022
Q2
$4.19M Buy
301,913
+39,533
+15% +$548K 0.01% 1185
2022
Q1
$3.73M Sell
262,380
-39,529
-13% -$562K 0.01% 1260
2021
Q4
$4.1M Sell
301,909
-24,711
-8% -$336K 0.01% 1240
2021
Q3
$5.34M Sell
326,620
-4,575
-1% -$74.8K 0.01% 1053
2021
Q2
$5.57M Buy
331,195
+65,824
+25% +$1.11M 0.01% 1021
2021
Q1
$4.83M Hold
265,371
0.01% 1032
2020
Q4
$4.83M Buy
265,371
+52,612
+25% +$957K 0.01% 987
2020
Q3
$3.83M Sell
212,759
-74,260
-26% -$1.34M 0.01% 994
2020
Q2
$5.17M Sell
287,019
-66,651
-19% -$1.2M 0.02% 847
2020
Q1
$5.4M Buy
353,670
+7,667
+2% +$117K 0.02% 718
2019
Q4
$6.81M Sell
346,003
-20,118
-5% -$396K 0.02% 750
2019
Q3
$6.32M Sell
366,121
-13,089
-3% -$226K 0.02% 821
2019
Q2
$6.72M Buy
379,210
+54,805
+17% +$970K 0.02% 784
2019
Q1
$6.59M Buy
324,405
+36,174
+13% +$735K 0.02% 766
2018
Q4
$4.88M Buy
+288,231
New +$4.88M 0.02% 911